IVIg (Immunoglobuline intravenosa)
1 articolo — 2022-2022
RI
Ricerca
Due anni di MIS-C: peculiarità cliniche e orizzonti terapeutici
Mambelli L, Uva A, Iacono A, Del Vecchio L, Bianchedi I, Nuzzo A, Malta B, Marchetti F.
2022/5 — pag. 299-306 — DOI
Argomenti correlati
Adrenal Cortex Hormones (256)
COVID-19 (133)
Mucocutaneous Lymph Node Syndrome (119)
Immunoglobulins, Intravenous (103)
Kawasaki disease (95)
Treatment (87)
Diagnosis (83)
Malattia di Kawasaki (79)
SARS-CoV-2 (50)
Intravenous Immunoglobulin (IVIg) (25)
Systemic Inflammatory Response Syndrome (20)
Retrospective Studies (15)
Interleukin 1 Receptor Antagonist Protein (9)
MIS-C (8)
Multisystem Inflammatory Syndrome in Children (7)
Kawasaki Disease (KD) (6)
Complication (4)
complicanza (4)
Multisystem Inflammatory Syndrome in Children (MIS-C) (4)
Malattia di Kawasaki (MK) (4)
